Journal Logo

Poster Session II: Acute myeloid leukemia – Clinical

PS1025 IVOSIDENIB (AG-120) INDUCES DURABLE REMISSIONS AND TRANSFUSION INDEPENDENCE IN PATIENTS WITH IDH1-MUTANT NEWLY-DIAGNOSED AML: UPDATED RESULTS FROM A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

Roboz, G.J.1; DiNardo, C.D.2; Stein, E.M.3; Botton, S. de4; Mims, A.S.5; Prince, G.T.6; Altman, J.K.7; Arellano, M.L.8; Donnellan, W.9; Erba, H.P.10; Mannis, G.N.11; Pollyea, D.A.12; Stein, A.S.13; Uy, G.L.14; Watts, J.M.15; Fathi, A.T.16; Kantarjian, H.M.2; Tallman, M.S.3; Choe, S.17; Dai, D.17; Fan, B.17; Wang, H.17; Zhang, V.17; Yen, K.E.17; Kapsalis, S.M.17; Hickman, D.17; Liu, H.17; Agresta, S.17; Wu, B.17; Attar, E.C.17; Stone, R.M.18

Author Information
doi: 10.1097/01.HS9.0000562396.68284.e0
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.